IceCure Medical Ltd
ICCM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $56 | $49 | $57 | $87 |
| - Cash | $8 | $11 | $24 | $26 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $49 | $39 | $34 | $62 |
| Revenue | $3 | $3 | $3 | $4 |
| % Growth | 1.9% | 4.7% | -25.4% | – |
| Gross Profit | $1 | $1 | $1 | $2 |
| % Margin | 44.1% | 40.3% | 46.8% | 53% |
| EBITDA | -$15 | -$15 | -$16 | -$10 |
| % Margin | -466.8% | -472.4% | -534.6% | -231.9% |
| Net Income | -$15 | -$15 | -$17 | -$10 |
| % Margin | -465.5% | -453.8% | -558.1% | -243.3% |
| EPS Diluted | -0.3 | -0.32 | -0.47 | -0.35 |
| % Growth | 6.3% | 31.9% | -34.3% | – |
| Operating Cash Flow | -$13 | -$13 | -$14 | -$13 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$1 |
| Free Cash Flow | -$13 | -$13 | -$15 | -$13 |